- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Clinical-grade fusion proteins, aliquoted from commercial EU-Licensed medicines
Showing 1–12 of 16 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD80 , CD86 |
Fusion protein |
Orencia® |
25 mg/mL |
yes |
5 mg |
-80°C |
02/2023 |
194,40 € |
||
PlGF , VEGF-A , VEGF-B |
Fusion protein |
Zaltrap® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
-80°C |
11/2021 |
548,10 € |
||
CD80 , CD86 |
Fusion protein |
Nulojix® |
25 mg/mL |
– |
5 mg |
-80°C |
01/2025 |
214,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Erelzi® |
50 mg/mL |
– |
4 mg |
-80°C |
04/2023 |
237,60 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
6 mg |
-80°C |
01/2024 |
266,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Benepali® |
50 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
264,00 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
25 mg/mL |
– |
2 mg |
-80°C |
02/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
04/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
06/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
25 mg/mL |
– |
2 mg |
-80°C |
12/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
10/2019 |
171,90 € |
||
TNF alpha |
Fusion protein |
Enbrel® |
50 mg/mL |
– |
2 mg |
-80°C |
04/2020 |
171,90 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Nepexto® |
50 mg/mL |
– |
4 mg |
-80 °C |
08/2023 |
237,60 € |
||
TGF-beta |
Fusion protein |
Reblozyl® |
50 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
496,80 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin